ID: ALA3341858

Max Phase: Preclinical

Molecular Formula: C133H212N38O50

Molecular Weight: 3143.37

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O

Standard InChI:  InChI=1S/C133H212N38O50/c1-15-62(11)105(169-125(213)81(45-60(7)8)159-129(217)90(55-173)167-120(208)84(48-67-53-144-57-145-67)165-132(220)106(63(12)16-2)170-126(214)82(46-61(9)10)160-130(218)91(56-174)168-133(221)107(64(13)175)171-127(215)83(47-66-20-22-68(177)23-21-66)161-124(212)88(52-99(142)185)164-121(209)85(49-96(139)182)146-65(14)176)131(219)156-78(32-41-104(194)195)115(203)152-77(31-40-103(192)193)118(206)166-89(54-172)128(216)155-73(27-36-95(138)181)116(204)163-87(51-98(141)184)122(210)153-72(26-35-94(137)180)112(200)148-70(24-33-92(135)178)110(198)150-74(28-37-100(186)187)113(201)147-69(19-17-18-42-134)109(197)162-86(50-97(140)183)123(211)154-75(29-38-101(188)189)114(202)149-71(25-34-93(136)179)111(199)151-76(30-39-102(190)191)117(205)158-80(44-59(5)6)119(207)157-79(108(143)196)43-58(3)4/h20-23,53,57-64,69-91,105-107,172-175,177H,15-19,24-52,54-56,134H2,1-14H3,(H2,135,178)(H2,136,179)(H2,137,180)(H2,138,181)(H2,139,182)(H2,140,183)(H2,141,184)(H2,142,185)(H2,143,196)(H,144,145)(H,146,176)(H,147,201)(H,148,200)(H,149,202)(H,150,198)(H,151,199)(H,152,203)(H,153,210)(H,154,211)(H,155,216)(H,156,219)(H,157,207)(H,158,205)(H,159,217)(H,160,218)(H,161,212)(H,162,197)(H,163,204)(H,164,209)(H,165,220)(H,166,206)(H,167,208)(H,168,221)(H,169,213)(H,170,214)(H,171,215)(H,186,187)(H,188,189)(H,190,191)(H,192,193)(H,194,195)/t62-,63-,64+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,105-,106-,107-/m0/s1

Standard InChI Key:  JHGUPXOJCZAGNO-SZVFQVARSA-N

Associated Targets(non-human)

GP41 50 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3143.37Molecular Weight (Monoisotopic): 3141.5214AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Lu L, Na H, Li X, Wang Q, Jiang X, Xu X, Yu F, Zhang T, Li J, Zhang Z, Zheng B, Liang G, Cai L, Jiang S, Liu K..  (2014)  Conjugation of a nonspecific antiviral sapogenin with a specific HIV fusion inhibitor: a promising strategy for discovering new antiviral therapeutics.,  57  (17): [PMID:25156906] [10.1021/jm500763m]

Source